COLLA, Simona
 Distribuzione geografica
Continente #
NA - Nord America 348
EU - Europa 265
AS - Asia 137
AF - Africa 2
OC - Oceania 1
Totale 753
Nazione #
US - Stati Uniti d'America 347
CN - Cina 102
IE - Irlanda 92
IT - Italia 57
SE - Svezia 50
SG - Singapore 26
DE - Germania 23
FI - Finlandia 15
CZ - Repubblica Ceca 6
UA - Ucraina 6
FR - Francia 4
IL - Israele 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 2
CI - Costa d'Avorio 2
PT - Portogallo 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
IN - India 1
LU - Lussemburgo 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 753
Città #
Chandler 112
Dublin 89
Shanghai 35
Ashburn 31
Boardman 28
Parma 27
Singapore 19
Beijing 18
Princeton 13
Bremen 9
Wilmington 9
Dearborn 8
Milan 8
Nanjing 7
Santa Clara 7
Bologna 5
Brno 5
Jacksonville 5
Kunming 5
San Mateo 5
Hefei 4
Houston 4
Izmir 4
Marseille 4
New York 4
Shenyang 4
Changsha 3
Des Moines 3
Hebei 3
Helsinki 3
Jiaxing 3
Lviv 3
Nanchang 3
Rho 3
Vienna 3
Woodbridge 3
Abidjan 2
Ann Arbor 2
Brussels 2
Hangzhou 2
Pescara 2
San Giuliano Milanese 2
Sassuolo 2
Tel Aviv 2
Tianjin 2
Washington 2
West Jordan 2
Zhengzhou 2
Casoria 1
Chengdu 1
Chicago 1
Dallas 1
Düsseldorf 1
Eboli 1
Fairfield 1
Forest City 1
Frankfurt am Main 1
Geislingen an der Steige 1
Huizen 1
Kolkata 1
Los Angeles 1
Luxembourg 1
Male Hostice 1
Manassas 1
Munich 1
Palermo 1
Perth 1
Redmond 1
Rockville 1
Seattle 1
Sofia 1
Taizhou 1
Toronto 1
Turin 1
Viterbo 1
Waterford 1
Totale 551
Nome #
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 71
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome 69
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 67
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 65
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome 64
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy 60
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 52
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 51
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 50
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function 46
PAF promotes stemness and radioresistance of glioma stem cells 43
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer 37
RNA processing: A new player of genomic instability in multiple myeloma 37
Down-regulation of EZH2 expression in myelodysplastic syndromes 30
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4) 24
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma 11
Totale 777
Categoria #
all - tutte 3.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 1 2 4 7 4 2 8 7 1
2020/202116 0 1 0 10 1 0 1 0 1 1 1 0
2021/202264 7 0 0 0 2 0 1 5 11 6 1 31
2022/2023341 23 40 14 39 28 39 16 19 107 2 12 2
2023/2024174 9 8 3 4 12 20 39 6 10 15 13 35
2024/202549 7 17 21 4 0 0 0 0 0 0 0 0
Totale 777